spacer
home > epc > spring 2019 > smarter supply chains
PUBLICATIONS
European Pharmaceutical Contractor

Smarter Supply Chains

The role of the supply chain in protecting patients from unsafe medical products is crucial, with the transportation and storage of pharmaceuticals having a significant impact on product integrity. However, with the growth of biopharmaceuticals, the significance of getting logistics right becomes even more important. The stricter logistical requirements and significant costs are combined with limited supply, meaning that every batch is vital. This article will consider how supply chains can work smarter to mitigate the risks that cause product failures and better protect end-patients.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
James Colson has principally worked in the European road sector, including both own accounts and third party. More recently, this has expanded to air and ocean environments too, with a focus on healthcare solutions for pharmaceutical customers. James' in-depth knowledge has led to him heading up the internal Yusen team that is focused on Brexit, and the impacts and implications for both Yusen and our customers.

Ellena Austin has carved a career in Marketing with a vast range of experience from fashion PR to corporate events and copywriting for a number of verticals including Healthcare, Consumer Electronics and White Goods. Currently working as Marketing Executive for Yusen Logistics UK, Ellena executes the UK marketing strategy in line with regional and global directives. Within her company she holds Regional Brand Ambassador and Regional Connected Ambassador roles, representing the EU region.
spacer
Ellena Austin
spacer
spacer
spacer
James Colson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Appoints Paul Drake as Chief Compliance and Security Officer

PHILADELPHIA, PA – December 17, 2019: Signant Health, announced today that it has appointed Paul Drake, PhD, MSc, as Chief Compliance and Security Officer. This role combines quality management, information security, physical security and regulatory compliance and is part of Signant Health’s ongoing commitment to invest in quality and data protection while accelerating innovation.
More info >>

White Papers

The BioPharmaSpec Approach”: Mass Spectrometry Based Host Cell Protein Identification and Quantitation

BioPharmaSpec

1. Introduction As part of the development of any biopharmaceutical product, the impurities present must be examined, minimized and where possible characterized (1). These impurities fall into two broad categories: product-related impurities (derived specifically from the drug product itself) and process-related impurities (derived from material associated with the production, processing or purification of the sample). Host cell proteins (HCPs) are process-related impurities that require specific analysis due to the multitude of naturally occurring proteins expressed in the production cell line.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement